Humana
HUMANA INC
Key figures
Period Jan 2025 to Dec 2025ConsolidatedU.S. GAAP
RevenueDisclosed
US$129.7B
Operating marginCalculated
2.1%
Net assets to total assetsCalculated
36.1%
Company profile
Tables scroll sideways
Disclosed data
Profitability
★☆☆☆☆position among all companies
2.1%
Growth (revenue, 4-year average)
★★★★☆position among all companies
11.8%
Capital efficiency
★★☆☆☆position among all companies
6.7%
Revenue and profit
Performance, financial position and capital allocation
Humana
Recent performance trends
Humana
Cash flow trends
Consolidated indicators (9 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$83.1 billion | US$92.9 billion | US$106.4 billion | US$117.8 billion | US$129.7 billion |
| Operating income | US$3.1 billion | US$3.8 billion | US$4.0 billion | US$2.6 billion | US$2.7 billion |
| Net income | US$2.9 billion | US$2.8 billion | US$2.5 billion | US$1.2 billion | US$1.2 billion |
| Total assets | US$44.4 billion | US$43.1 billion | US$47.1 billion | US$46.5 billion | US$48.9 billion |
| Shareholders' equity | US$16.1 billion | US$15.3 billion | US$16.3 billion | US$16.4 billion | US$17.7 billion |
| Net cash provided by (used in) operating activities | US$2.3 billion | US$4.6 billion | US$4.0 billion | US$3.0 billion | US$0.9 billion |
| Net cash provided by (used in) investing activities | US$-6.6 billion | US$-1.0 billion | US$-3.5 billion | US$-3.0 billion | US$2.3 billion |
| Net cash provided by (used in) financing activities | US$3.0 billion | US$-1.9 billion | US$-0.9 billion | US$-2.5 billion | US$-1.2 billion |
| Cash and cash equivalents | US$3.4 billion | US$5.1 billion | US$4.7 billion | US$2.2 billion | US$4.2 billion |
Revenue scale in the same industry
Humana
Insurance carriers: 54 companies · revenue · largest first・FY Dec 2025・Consolidated・Disclosed
- 1 UnitedHealth Group US$447.6B
- 2 Berkshire Hathaway US$371.4B
- 3 The Cigna Group US$274.9B
- 4 Elevance Health US$199.1B
- 5 Centene US$194.8B
- 6 HumanaThis company US$129.7B
- 7 Progressive CORP/OH/ US$87.7B
- 8 MetLife US$77.1B
- … 46 companies
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Purchase of property, plant and equipment | US$0.5 billion | Consolidated | Disclosed |
| Cash and cash equivalents | US$4.2 billion | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$-1.2 billion | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$2.3 billion | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$0.9 billion | Consolidated | Disclosed |
| Depreciation and amortization | US$0.7 billion | Consolidated | Disclosed |
| Dividends paid | US$0.4 billion | Consolidated | Disclosed |
| Stockholders' equity (including non-controlling interests) | US$17.7 billion | Consolidated | Disclosed |
| Non-controlling interests | US$80.00 million | Consolidated | Disclosed |
| Net assets | US$17.7 billion | Consolidated | Disclosed |
| Net sales | US$129.7 billion | Consolidated | Disclosed |
| Operating income | US$2.7 billion | Consolidated | Disclosed |
| Net income | US$1.2 billion | Consolidated | Disclosed |
| Total assets | US$48.9 billion | Consolidated | Disclosed |
| Purchase of treasury stock | US$0.2 billion | Consolidated | Disclosed |
| Operating margin | 2.1% | Consolidated | Calculated |
| Net assets to total assets | 36.1% | Consolidated | Calculated |
| Net margin | 0.9% | Consolidated | Calculated |
| Return on equity | 6.7% | Consolidated | Calculated |